Docetaxel in combination carboplatin as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer

被引：0
|
作者：
Barata, F
Camacho, E
Sousa, A
Costa, MS
Resende, R
Meleiro, A
Nogueira, F
Pereira, A
Canário, D
机构：
[1] Ctr Hosp Coimbra, Coimbra, Portugal
[2] Hosp Nossa Senhora Rosario, Barreiro, Portugal
[3] Hosp Univ Coimbra, Coimbra, Portugal
[4] Hosp Distrital Santarem, Santarem, Portugal
[5] Hosp Amato Lusitano, Castelo Branco, Portugal
[6] Hosp S Bernardo, Setubal, Portugal
[7] Hosp Egas Moniz, Lisbon, Portugal
[8] Hosp Distrital Fig Foz, Figueira Foz, Portugal
[9] Hosp Garcis Orta, Almada, Portugal
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [11] Elderly subset analysis of randomized phase III study comparing pemetrexed plus carboplatin with docetaxel plus carboplatin as first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer
    Pereira J.R.
    Cheng R.
    Orlando M.
    Kim J.-H.
    Barraclough H.
    Drugs in R&D, 2013, 13 (4) : 289 - 296
  • [12] Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer
    Chang, Myung Hee
    Kim, Kyoung Ha
    Jun, Hyun Jung
    Kim, Hyo Song
    Yi, Seong Yoon
    Uhm, Ji Eun
    Park, Min Jae
    Lim, Do Hyoung
    Ji, Sang Hoon
    Hwang, In Gyu
    Lee, Jeeyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Ahn, Myung-ju
    Park, Keunchil
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (05) : 917 - 924
  • [13] Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer
    Myung Hee Chang
    Kyoung Ha Kim
    Hyun Jung Jun
    Hyo Song Kim
    Seong Yoon Yi
    Ji Eun Uhm
    Min Jae Park
    Do Hyoung Lim
    Sang Hoon Ji
    In Gyu Hwang
    Jeeyun Lee
    Yeon Hee Park
    Jin Seok Ahn
    Myung-ju Ahn
    Keunchil Park
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 917 - 924
  • [14] Phase II study of meloxicam with carboplatin plus docetaxel in first-line treatment of patients with advanced non-small cell lung cancer (NSCLC)
    Ishida, T.
    Kanazawa, K.
    Oizumi, H.
    Yokouchi, H.
    Yamazaki, K.
    Akie, K.
    Sukoh, N.
    Harada, M.
    Munakata, M.
    Isobe, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [15] Immunochemotherapy as First-line Treatment for Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancers
    Huang, Shujie
    Gao, Zhen
    Qiao, Guibin
    JAMA ONCOLOGY, 2021, 7 (10) : 1580 - 1580
  • [16] First-line combination immunotherapy for metastatic non-small cell lung cancer
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (05) : 433 - 441
  • [17] A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Nokihara, Hiroshi
    Horai, Takeshi
    Nishio, Makoto
    Ohyanagi, Fumiyoshi
    Horiike, Atsushi
    Nakagawa, Kazuhiko
    Terashima, Masaaki
    Okabe, Takafumi
    Kaneda, Hiroyasu
    McKee, Mark D.
    Carlson, Dawn M.
    Xiong, Hao
    Tamura, Tomohide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 37 - 43
  • [18] A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)
    Hidehito Horinouchi
    Noboru Yamamoto
    Hiroshi Nokihara
    Takeshi Horai
    Makoto Nishio
    Fumiyoshi Ohyanagi
    Atsushi Horiike
    Kazuhiko Nakagawa
    Masaaki Terashima
    Takafumi Okabe
    Hiroyasu Kaneda
    Mark D. McKee
    Dawn M. Carlson
    Hao Xiong
    Tomohide Tamura
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 37 - 43
  • [19] Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
    W. Schuette
    I. Bork
    B. Wollschläger
    S. Schädlich
    Clinical Drug Investigation, 2001, 21 : 161 - 168
  • [20] Combination chemotherapy with docetaxel and carboplatin for advanced non-small cell lung cancer
    Schuette, W
    Bork, I
    Wollschläger, B
    Schädlich, S
    CLINICAL DRUG INVESTIGATION, 2001, 21 (03) : 161 - 168
12345